Expertise in
5
conditions

Mark M. Gompels

Bristol, ENG, GB 
Expertise in
5
conditions
Bristol, ENG, GB 

Overview

Mark Gompels practices practicing medicine in Bristol, United Kingdom.

Mr. Gompels is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Angioedema, Hereditary Angioedema, Hives, and HIV/AIDS.

He is actively involved in clinical research, co-authoring 74 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Bristol, ENG, United Kingdom
Other Locations
Westbury On Trym, ENG, United Kingdom
Barts Health NHS Trust
London, ENG, United Kingdom
United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

An Open-Label, Multi-Centre, Randomised Study to Investigate Integrase Inhibitor Versus Boosted Protease Inhibitor Antiretroviral Therapy for Patients With Advanced HIV Disease
An Open-Label, Multi-Centre, Randomised Study to Investigate Integrase Inhibitor Versus Boosted Protease Inhibitor Antiretroviral Therapy for Patients With Advanced HIV Disease
Enrollment Status: Completed
Publish Date: December 17, 2025
Intervention Type: Drug
Study Drugs: Biktarvy, Symtuza
Study Phase: Phase 3
A Phase III, Randomized, Multicenter, Parallel-group, Non-inferiority Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Dolutegravir Plus Lamivudine in HIV-1 Infected Adults Who Are Virologically Suppressed
A Phase III, Randomized, Multicenter, Parallel-group, Non-inferiority Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Dolutegravir Plus Lamivudine in HIV-1 Infected Adults Who Are Virologically Suppressed
Enrollment Status: Completed
Publish Date: July 19, 2023
Intervention Type: Drug
Study Drugs: Dolutegravir+Lamivudine, Tenofovir alafenamide based regimen
Study Phase: Phase 3
View 1 Less Clinical Trial

74 Total Publications

A multicentre evaluation of cardiovascular risk prediction tools in people living with HIV across England (ECARTH study).
A multicentre evaluation of cardiovascular risk prediction tools in people living with HIV across England (ECARTH study).
Journal: HIV medicine
Published: December 08, 2025

Frequently Asked Questions about Mark M. Gompels

Is Mark M. Gompels a top-rated expert for Angioedema?

MediFind is an objective health platform that identifies experts based on real-world data. Mark M. Gompels is classified as an Distinguished expert for Angioedema, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Mark M. Gompels participate in research or clinical trials?

Yes. Mark M. Gompels has published 74 articles and abstracts on conditions like Angioedema. You can view a list of Mark M. Gompels's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Gompels's expertise for a condition
ConditionClose
    View All 17 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile